A nitroreductase-responsive fluorescence turn-on photosensitizer for lysosomes imaging and photodynamic therapy
View abstract on PubMed
Summary
This summary is machine-generated.A novel probe, M-TPE-P, effectively detects hypoxia biomarker nitroreductase (NTR) in lysosomes. It shows potential as a photosensitizer for cancer therapy via reactive oxygen species generation.
Area Of Science
- Biomedical Engineering
- Chemical Biology
- Molecular Imaging
Background
- Nitroreductase (NTR) is a key biomarker for tumor hypoxia.
- Lysosomal dysfunction is linked to various diseases.
- Developing targeted probes for disease assessment is crucial.
Purpose Of The Study
- To design and synthesize an NTR-triggered, lysosome-targeting probe (M-TPE-P).
- To evaluate M-TPE-P as a potential photosensitizer for cancer therapy.
- To assess the probe's efficacy in detecting NTR and its lysosomal targeting specificity.
Main Methods
- Tetraphenylethylene-based probe M-TPE-P synthesis.
- Density Functional Theory (DFT) calculations for photophysical properties.
- Docking studies to assess M-TPE-P affinity for NTR.
- In vitro assays for selectivity, sensitivity, and detection limit.
- Cell imaging and colocalization studies for lysosomal targeting.
- Evaluation of reactive oxygen species (ROS) generation and photodynamic therapy (PDT) effects.
Main Results
- M-TPE-P demonstrated a narrow singlet-triplet energy gap, indicating efficient photosensitization.
- High selectivity and sensitivity for NTR detection across a broad pH range (kcat/Km = 2.18 × 10^4 M^-1 s^-1).
- Low detection limit of 53.6 ng/mL in 80% PBS/DMSO.
- Successful intracellular NTR tracing with green fluorescence and excellent lysosome-targeting specificity.
- Effective ROS generation and significant PDT effect upon NIR irradiation.
Conclusions
- M-TPE-P is a highly selective and sensitive probe for NTR detection, with specific lysosomal targeting.
- The probe's photophysical properties and ability to generate ROS position it as a promising candidate for cancer photodynamic therapy.

